Alphabet’s Solid Second-Quarter Results Show That It’s Still Got It, And The US Is Threatening 100% Tariffs On Foreign-Made Generic Drugs

from The Finimize Daily Brief · host Finimize

Google parent Alphabet’s second-quarter results came in just as expected on Wednesday, and the US administration wants international drugmakers to bring production stateside – and now, they have until 2028 to get with the program or face 100% tariffs on some meds.Try Finimize Pro

Episode metadata supplied by the publisher feed · Published Jul 23, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Alphabet’s Solid Second-Quarter Results Show That It’s Still Got It, And The US Is Threatening 100% Tariffs On Foreign-Made Generic Drugs

0:00 5:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Finimize Daily Brief?

This episode is 5 minutes long.

When was this The Finimize Daily Brief episode published?

This episode was published on July 23, 2026.

Can I download this The Finimize Daily Brief episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!